US Stock MarketDetailed Quotes

SYRA Syra Health

Watchlist
  • 1.320
  • +0.030+2.33%
Trading Jul 5 15:13 ET
19.48MMarket Cap-5176P/E (TTM)

Syra Health Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-1,676.99%-800.75K
-22.95%-2.76M
-43.85%-1.76M
6.80%-369.26K
-35.31%-587.7K
76.55%-45.06K
-2,444.32%-2.24M
-1.22M
-396.21K
-434.33K
Net income from continuing operations
-84.13%-1.45M
-38.72%-2.94M
-62.46%-995.28K
0.04%-354.38K
-27.95%-802.8K
-50.10%-785.89K
-64,478.20%-2.12M
---612.63K
---354.54K
---627.41K
Depreciation and amortization
6.65%12.55K
228.45%48.77K
22.87%12.36K
218.48%12.36K
1,962.58%12.29K
3,634.29%11.76K
7,073.43%14.85K
--10.06K
--3.88K
--596
Other non cash items
69.62%50.25K
-80.46%121.09K
-6.74%30.93K
-6.90%30.49K
-65.68%30.05K
-93.65%29.62K
2,173.15%619.64K
--33.16K
--32.75K
--87.57K
Change In working capital
-18.44%569.37K
96.93%-23.42K
-26.09%-824.29K
25.98%-58.81K
54.03%161.61K
617.03%698.08K
-579.18%-763.3K
---653.75K
---79.45K
--104.92K
-Change in receivables
-66.07%283.44K
88.29%-110.16K
57.86%-246.49K
-432.96%-641.82K
84.19%-57.31K
549.93%835.46K
-260.85%-940.47K
---584.99K
--192.76K
---362.56K
-Change in payables and accrued expense
6,510.82%303.3K
-99.00%4.72K
-1,179.45%-549.37K
247.86%437.39K
-78.49%121.43K
-103.08%-4.73K
140.37%473.53K
--50.89K
---295.82K
--564.61K
-Change in other current assets
107.67%7.9K
201.15%203.11K
259.34%144.13K
-34.22%34.47K
273.56%127.54K
-15.43%-103.03K
-833.77%-200.8K
---90.46K
--52.39K
---73.48K
-Change in other current liabilities
-5.90%-31.37K
-26.71%-121.09K
-5.91%-30.93K
-5.91%-30.49K
-27.08%-30.05K
-112.72%-29.62K
-250.57%-95.56K
---29.2K
---28.79K
---23.65K
-Change in other working capital
--6.11K
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-1,676.99%-800.75K
-22.95%-2.76M
-43.85%-1.76M
6.80%-369.26K
-35.31%-587.7K
76.55%-45.06K
-2,444.32%-2.24M
---1.22M
---396.21K
---434.33K
Investing cash flow
Cash flow from continuing investing activities
41.83%-5.62K
87.42%-15.25K
0
0
54.93%-5.59K
-9.66K
-1,828.13%-121.26K
-44.9K
-63.95K
-12.41K
Net PPE purchase and sale
41.83%-5.62K
87.42%-15.25K
--0
--0
54.93%-5.59K
---9.66K
-1,828.13%-121.26K
---44.9K
---63.95K
---12.41K
Cash from discontinued investing activities
Investing cash flow
41.83%-5.62K
87.42%-15.25K
--0
--0
54.93%-5.59K
---9.66K
-1,828.13%-121.26K
---44.9K
---63.95K
---12.41K
Financing cash flow
Cash flow from continuing financing activities
17.98%764.25K
166.72%6.05M
734.96%5.02M
234.58%350.82K
-94.72%33.33K
-30.48%647.79K
1,084.68%2.27M
601.12K
104.85K
630.87K
Net issuance payments of debt
-110.69%-85.88K
-29.56%518.76K
-164.73%-485.85K
--0
175.21%201.56K
363.33%803.05K
245,391.67%736.48K
--750.55K
---260.64K
--73.24K
Net common stock issuance
----
129.59%5.33M
--5.33M
--0
----
----
--2.32M
--0
--514.92K
--807.58K
Proceeds from stock option exercised by employees
--850.13K
----
----
----
----
--0
----
----
----
----
Net other financing activities
----
125.31%200.01K
215.55%172.67K
334.77%350.82K
32.70%-168.22K
35.71%-155.26K
-513.35%-790.32K
---149.43K
---149.43K
---249.95K
Cash from discontinued financing activities
Financing cash flow
17.98%764.25K
166.72%6.05M
734.96%5.02M
234.58%350.82K
-94.72%33.33K
-30.48%647.79K
1,084.68%2.27M
--601.12K
--104.85K
--630.87K
Net cash flow
Beginning cash position
97,988.37%3.28M
-96.66%3.34K
-97.31%18.01K
-96.44%36.45K
-28.97%596.41K
-96.66%3.34K
3,233.73%100.01K
--668.53K
--1.02M
--839.7K
Current changes in cash
-107.10%-42.12K
3,489.67%3.28M
590.40%3.26M
94.81%-18.44K
-404.10%-559.96K
-19.82%593.07K
-199.65%-96.67K
---665.19K
---355.31K
--184.14K
End cash Position
442.91%3.24M
97,988.37%3.28M
97,988.37%3.28M
-97.31%18.01K
-96.44%36.45K
-28.97%596.41K
-96.66%3.34K
--3.34K
--668.53K
--1.02M
Free cash flow
-1,373.59%-806.36K
-17.29%-2.77M
-38.75%-1.76M
19.75%-369.26K
-32.81%-593.29K
71.52%-54.72K
-2,403.31%-2.37M
---1.27M
---460.16K
---446.73K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -1,676.99%-800.75K-22.95%-2.76M-43.85%-1.76M6.80%-369.26K-35.31%-587.7K76.55%-45.06K-2,444.32%-2.24M-1.22M-396.21K-434.33K
Net income from continuing operations -84.13%-1.45M-38.72%-2.94M-62.46%-995.28K0.04%-354.38K-27.95%-802.8K-50.10%-785.89K-64,478.20%-2.12M---612.63K---354.54K---627.41K
Depreciation and amortization 6.65%12.55K228.45%48.77K22.87%12.36K218.48%12.36K1,962.58%12.29K3,634.29%11.76K7,073.43%14.85K--10.06K--3.88K--596
Other non cash items 69.62%50.25K-80.46%121.09K-6.74%30.93K-6.90%30.49K-65.68%30.05K-93.65%29.62K2,173.15%619.64K--33.16K--32.75K--87.57K
Change In working capital -18.44%569.37K96.93%-23.42K-26.09%-824.29K25.98%-58.81K54.03%161.61K617.03%698.08K-579.18%-763.3K---653.75K---79.45K--104.92K
-Change in receivables -66.07%283.44K88.29%-110.16K57.86%-246.49K-432.96%-641.82K84.19%-57.31K549.93%835.46K-260.85%-940.47K---584.99K--192.76K---362.56K
-Change in payables and accrued expense 6,510.82%303.3K-99.00%4.72K-1,179.45%-549.37K247.86%437.39K-78.49%121.43K-103.08%-4.73K140.37%473.53K--50.89K---295.82K--564.61K
-Change in other current assets 107.67%7.9K201.15%203.11K259.34%144.13K-34.22%34.47K273.56%127.54K-15.43%-103.03K-833.77%-200.8K---90.46K--52.39K---73.48K
-Change in other current liabilities -5.90%-31.37K-26.71%-121.09K-5.91%-30.93K-5.91%-30.49K-27.08%-30.05K-112.72%-29.62K-250.57%-95.56K---29.2K---28.79K---23.65K
-Change in other working capital --6.11K------------------------------------
Cash from discontinued investing activities
Operating cash flow -1,676.99%-800.75K-22.95%-2.76M-43.85%-1.76M6.80%-369.26K-35.31%-587.7K76.55%-45.06K-2,444.32%-2.24M---1.22M---396.21K---434.33K
Investing cash flow
Cash flow from continuing investing activities 41.83%-5.62K87.42%-15.25K0054.93%-5.59K-9.66K-1,828.13%-121.26K-44.9K-63.95K-12.41K
Net PPE purchase and sale 41.83%-5.62K87.42%-15.25K--0--054.93%-5.59K---9.66K-1,828.13%-121.26K---44.9K---63.95K---12.41K
Cash from discontinued investing activities
Investing cash flow 41.83%-5.62K87.42%-15.25K--0--054.93%-5.59K---9.66K-1,828.13%-121.26K---44.9K---63.95K---12.41K
Financing cash flow
Cash flow from continuing financing activities 17.98%764.25K166.72%6.05M734.96%5.02M234.58%350.82K-94.72%33.33K-30.48%647.79K1,084.68%2.27M601.12K104.85K630.87K
Net issuance payments of debt -110.69%-85.88K-29.56%518.76K-164.73%-485.85K--0175.21%201.56K363.33%803.05K245,391.67%736.48K--750.55K---260.64K--73.24K
Net common stock issuance ----129.59%5.33M--5.33M--0----------2.32M--0--514.92K--807.58K
Proceeds from stock option exercised by employees --850.13K------------------0----------------
Net other financing activities ----125.31%200.01K215.55%172.67K334.77%350.82K32.70%-168.22K35.71%-155.26K-513.35%-790.32K---149.43K---149.43K---249.95K
Cash from discontinued financing activities
Financing cash flow 17.98%764.25K166.72%6.05M734.96%5.02M234.58%350.82K-94.72%33.33K-30.48%647.79K1,084.68%2.27M--601.12K--104.85K--630.87K
Net cash flow
Beginning cash position 97,988.37%3.28M-96.66%3.34K-97.31%18.01K-96.44%36.45K-28.97%596.41K-96.66%3.34K3,233.73%100.01K--668.53K--1.02M--839.7K
Current changes in cash -107.10%-42.12K3,489.67%3.28M590.40%3.26M94.81%-18.44K-404.10%-559.96K-19.82%593.07K-199.65%-96.67K---665.19K---355.31K--184.14K
End cash Position 442.91%3.24M97,988.37%3.28M97,988.37%3.28M-97.31%18.01K-96.44%36.45K-28.97%596.41K-96.66%3.34K--3.34K--668.53K--1.02M
Free cash flow -1,373.59%-806.36K-17.29%-2.77M-38.75%-1.76M19.75%-369.26K-32.81%-593.29K71.52%-54.72K-2,403.31%-2.37M---1.27M---460.16K---446.73K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg